Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droxidopa for Brain Perfusion in PD with NOH
NCT03229174Phase 4Completed
- Start
- Aug 2018
- Primary completion
- Feb 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of droxidopa in Neurogenic Orthostatic Hypotension (nOH). Started Aug 2018; status: completed.
02
Drugs
droxidopa
03
Conditions
Neurogenic Orthostatic Hypotension (nOH)
Beyond the preview
Go deeper on NCT03229174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03229174.